Literature DB >> 25912907

Pleiotropic Effects of Angiotensin II Receptor Signaling in Cardiovascular Homeostasis and Aging.

Takehiro Kamo1, Hiroshi Akazawa, Issei Komuro.   

Abstract

Most of the pathophysiological actions of angiotensin II (Ang II) are mediated through the Ang II type 1 (AT1) receptor, a member of the seven-transmembrane G protein-coupled receptor family. Essentially, AT1 receptor signaling is beneficial for organismal survival and procreation, because it is crucial for normal organ development, and blood pressure and electrolyte homeostasis. On the other hand, AT1 receptor signaling has detrimental effects, such as promoting various aging-related diseases that include cardiovascular diseases, diabetes, chronic kidney disease, dementia, osteoporosis, and cancer. Pharmacological or genetic blockade of AT1 receptor signaling in rodents has been shown to prevent the progression of aging-related phenotypes and promote longevity. In this way, AT1 receptor signaling exerts antagonistic and pleiotropic effects according to the ages and pathophysiological conditions. Here we review the pleiotropic effects of AT1 receptor signaling in cardiovascular homeostasis and aging.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25912907     DOI: 10.1536/ihj.14-429

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  11 in total

1.  The Role of Cyclooxygenase Enzymes in the Effects of Losartan and Lisinopril on the Contractions of Rat Thoracic Aorta.

Authors:  Fikriye Yasemin Ozatik; Bilgin Kaygisiz; Kevser Erol
Journal:  Eurasian J Med       Date:  2017-02

Review 2.  ATRAP, a receptor-interacting modulator of kidney physiology, as a novel player in blood pressure and beyond.

Authors:  Kouichi Tamura; Kengo Azushima; Sho Kinguchi; Hiromichi Wakui; Takahiro Yamaji
Journal:  Hypertens Res       Date:  2021-10-12       Impact factor: 3.872

3.  Mechanisms of Mas1 Receptor-Mediated Signaling in the Vascular Endothelium.

Authors:  Brian R Hoffmann; Timothy J Stodola; Jordan R Wagner; Daniela N Didier; Eric C Exner; Julian H Lombard; Andrew S Greene
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-01-12       Impact factor: 8.311

Review 4.  Roles of renin-angiotensin system and Wnt pathway in aging-related phenotypes.

Authors:  Takehiro Kamo; Hiroshi Akazawa; Jun-Ichi Suzuki; Issei Komuro
Journal:  Inflamm Regen       Date:  2016-08-09

5.  Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis.

Authors:  Aline Silva Miranda; Ana Cristina Simões E Silva
Journal:  World J Gastroenterol       Date:  2017-12-28       Impact factor: 5.742

6.  Specific calpain inhibition protects kidney against inflammaging.

Authors:  Guillaume Hanouna; Laurent Mesnard; Sophie Vandermeersch; Joëlle Perez; Sandrine Placier; Jean-Philippe Haymann; Fabien Campagne; Julien Moroch; Aurélien Bataille; Laurent Baud; Emmanuel Letavernier
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

Review 7.  Renin angiotensin system in liver diseases: Friend or foe?

Authors:  Ana Cristina Simões E Silva; Aline S Miranda; Natália P Rocha; Antônio L Teixeira
Journal:  World J Gastroenterol       Date:  2017-05-21       Impact factor: 5.742

8.  Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression.

Authors:  Chizuru Yabumoto; Hiroshi Akazawa; Rie Yamamoto; Masamichi Yano; Yoko Kudo-Sakamoto; Tomokazu Sumida; Takehiro Kamo; Hiroki Yagi; Yu Shimizu; Akiko Saga-Kamo; Atsuhiko T Naito; Toru Oka; Jong-Kook Lee; Jun-Ichi Suzuki; Yasushi Sakata; Etsuko Uejima; Issei Komuro
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

Review 9.  Mechanism of increased risk of insulin resistance in aging skeletal muscle.

Authors:  Jian Shou; Pei-Jie Chen; Wei-Hua Xiao
Journal:  Diabetol Metab Syndr       Date:  2020-02-11       Impact factor: 3.320

Review 10.  Receptor-Mediated Muscle Homeostasis as a Target for Sarcopenia Therapeutics.

Authors:  Jong Hyeon Yoon; Ki-Sun Kwon
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.